About STATICH

STATICH is a Scandinavian, investigator-led, randomised, open, blinded end-point (PROBE) clinical trial of antithrombotic treatment for prevention of ischaemic events after intracerebral haemorrhage.

The trial Sponsor is Oslo University Hospital. The Trial Co-ordinating Centre is Oslo University Hospital in collaboration with Akershus University Hospital.

For information about the background and methods, please see the protocol under “Documents”.



Contact information


STATICH Co-ordinating Centre
Oslo University Hospital, Ullevål
Department of Geriatric Medicine, Building 20, 4th floor
P.O. Box 4950 Nydalen
NO-0424 Oslo
Norway

Tel./fax: +47 22 11 99 11/12

Trial Manager
Kristin T. Larsen
k.t.larsen(a)medisin.uio.no


Trial Co-ordinating Investigator
Ole Morten Rønning
o.m.ronning(a)medisin.uio.no


Trial Co-ordinating Investigator
Torgeir Bruun Wyller
t.b.wyller(a)medisin.uio.no


National Co-ordinating Investigator in Sweden
Johanna Pennlert
johanna.pennlert(a)umu.se

Dept. of Public Health and Clinical Medicine
Umeå University Hospital
SE-90185 Umeå
Sweden


National Co-ordinating Investigator in Sweden
Eva-Lotta Glader
eva-lotta.glader(a)umu.se

Dept. of Public Health and Clinical Medicine
Umeå University Hospital
SE-90185 Umeå
Sweden


National Co-ordinating Investigator in Denmark
Christina Kruuse
christina.kruuse(a)regionh.dk

Dept. of Neurology, Stroke Unit N108
Herlev Gentofte Hospital
Herlev Ringvej 75
DK-2730 Herlev
Denmark